PTC Therapeutics (PTCT) – Analyst Ratings
-
Morgan Stanley Downgrades PTC Therapeutics (PTCT) to Underweight
-
Wells Fargo Starts PTC Therapeutics (PTCT) at Overweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PTCT Stock Lookup